Corrigendum to "Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K/Akt/NF-κB signaling pathway in human endothelial cells" [Immunobiology 220 (2015) 399-405] DOI: 10.1016/j.imbio.2014.10.008;Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K/Akt/NF-κB signaling pathway in human endothelial cells

Immunobiology

Volumn 220, Issue 3, 2015, Pages 399-405

  Li, Xu ^a   Liu, Yina ^a   Wang, Liang ^a   Li, Zhiliang ^a   Ma, Xiaochun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cells; Lipopolysaccharide; Nuclear factor B; Phosphoinositide 3 kinase; Unfractionated heparin

Indexed keywords

HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PULMONARY MICROVASCULAR ENDOTHELIAL CELL; IL 6 GENE; IL 8 GENE; INHIBITION KINETICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84964225109     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.05.016     Document Type: Erratum

References (29)

1. Abraham E., Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit. Care Med. 2007, 35:2408-2416.
2. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., Fisher C.J.J.R. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 2001, 344:699-707.
3. Birkenkamp K.U., Esselink M.T., Kruijer W., Vellenga E. An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation. Exp. Hematol. 2000, 28:1239-1249.
4. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
5. Carpenter C.L., Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 1996, 8:153-158.
6. Deane J.A., Fruman D.A. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 2004, 22:563-598.
7. Freischlag J.A., Colburn M.D., Quiñones-Baldrich W.J., Moore W.S. Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J. Surg. Res. 1992, 52:523-529.
8. Fruman D.A., Bismuth G. Fine tuning the immune response with PI3K. Immunol. Rev. 2009, 228:253-272.
9. Goyal A., Wang Y., Graham M.M., Doseff A.I., Bhatt N.Y., Marsh C.B. Monocyte survival factors induce Akt activation and suppress caspase-3. Am. J. Respir. Cell Mol. Biol. 2002, 26:224-230.
10. Gray E., Mulloy B., Barrowcliffe T.W. Heparin and low-molecular-weight heparin. Thromb. Haemost. 2008, 99:807-818.
11. Harada N., Okajima K., Uchiba M. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. Crit. Care Med. 2006, 34:1883-1891.
12. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Gene. Dev. 2004, 18:2195-2224.
13. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000, 287:1049-1053.
14. Hoffmann A., Baltimore D. Circuitry of nuclear factor (B signaling). Immunol. Rev. 2006, 210:171-186.
15. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
16. Karin M., Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 1995, 5:747-757.
17. Koyasu S. The role of PI3K in immune cells. Nat. Immunol. 2003, 4:313-319.
18. Li X., Li Z.L., Zheng Z., Liu Y.N., Ma X.C. Unfractionated heparin ameliorates lipopolysaccharide-induced lung inflammation by downregulating nuclear factor-κB signaling pathway. Inflammation 2013, 36:1201-1208.
19. Li X., Tupper J.C., Bannerman D.D., Winn R.K., Rhodes C.J., Harian J.M. Phosphoinositide 3 kinase mediates Toll-like receptor 4- induced activation of NF-κB in endothelial cells. Infect. Immunol. 2003, 71:4414-4420.
20. Li X., Zheng Z., Li X., Ma X.C. Unfractionated heparin inhibits lipopolysaccharide- induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell. Cytokine 2012, 60:114-121.
21. Madge L.A., Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J. Biol. Chem. 2000, 275:15458-15465.
22. Matthay M.A. Severe sepsis - a new treatment with both anticoagulant and antiinflammatory properties. N. Engl. J. Med. 2001, 344:759-762.
23. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 2003, 3:317-330.
24. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995, 273:117-123.
25. Seger R., Krebs E. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
26. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999, 283:390-392.
27. Tyrell D.J., Kilfeather S., Page C.P. Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol. Sci. 1995, 16:198-204.
28. Yagmurdur M.C., Turk E., Moray G., Can F., Demirbilek M., Haberal N., Karabay G., Karakayali H., Haberal M. Effect of heparin on bacterial translocation and gut epithelial apoptosis after burn injury in the rat: dose-dependent inhibition of the complement cascade. Burns 2005, 31:603-609.
29. Yum H.K., Arcaroli J., Kupfner J., Shenkar R., Penninger J.M., Sasaki T., Yang K.Y., Park J.S., Abraham E. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J. Immunol. 2001, 167:6601-6608.